Fedratinib

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Treatment of intermediate-2 and high-risk primary and secondary myelofibrosis

Link	Tested on	Impact factor	Notes	Publication date
Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19 Preprint	Huh7 cells			May/27/2020

Link	Publication date
Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.	Aug/08/2020
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19	Apr/04/2022
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib	Apr/28/2020